# Trifluent Pharma, LLC – FDA 483, Jun 11, 2026

Source: https://www.keypedia.com/records/483/trifluent-pharma-llc/75798d1e-d637-4221-9e3b-83d49a24fa0e

> FDA 483 for Trifluent Pharma, LLC on June 11, 2026. Product: drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Trifluent Pharma, LLC
- Inspection Date: 2026-06-11
- Product Type: drugs
- Office Name: Dallas District Office
- Summary: Trifluent Pharma LLC, a repacker in San Antonio, TX, was cited for two significant issues during an FDA inspection. The firm lacked adequate written procedures for controlling and reconciling labeling during repackaging operations. Additionally, the inspection revealed a failure to implement a continuing GMP training program for employees involved in packaging, labeling, and quality-related activities.

## Related Officers

- [investigator](https://www.keypedia.com/people/kevin-t-nguyen/5ae9d562-7e4f-4305-895a-4b39c35acd16)
- [Investigator](https://www.keypedia.com/people/shanna-n-purdy/7a677cf5-484f-4e9a-91b1-27398411ff32)

Company: https://www.keypedia.com/companies/trifluent-pharma-llc/57969e2d-86a8-4a86-85b3-f9c3a740e3fc

Office: https://www.keypedia.com/offices/dallas-district-office/2d1ee9ae-c44c-4494-8186-a920a69b98f9